MARKET

PPBT

PPBT

Purple Biotech Ltd
NASDAQ
1.020
-0.090
-8.11%
Closed 19:58 09/20 EDT
OPEN
1.140
PREV CLOSE
1.110
HIGH
1.147
LOW
1.011
VOLUME
57.76K
TURNOVER
--
52 WEEK HIGH
2.370
52 WEEK LOW
1.011
MARKET CAP
21.43M
P/E (TTM)
-0.9348
1D
5D
1M
3M
1Y
5Y
Purple Biotech To Present New CM24 Pancreatic Cancer Biomarker Data At AACR Special Conference On September 28, 2023
Benzinga · 14h ago
Weekly Report: what happened at PPBT last week (0911-0915)?
Weekly Report · 3d ago
Weekly Report: what happened at PPBT last week (0904-0908)?
Weekly Report · 09/11 09:45
Weekly Report: what happened at PPBT last week (0828-0901)?
Weekly Report · 09/04 14:55
HC Wainwright & Co. Maintains Buy on Purple Biotech, Raises Price Target to $9
Benzinga · 08/30 15:20
H.C. Wainwright Remains a Buy on Purple Biotech (PPBT)
TipRanks · 08/30 15:15
Weekly Report: what happened at PPBT last week (0821-0825)?
Weekly Report · 08/28 09:47
Purple Biotech GAAP EPS of -$0.25
Seeking Alpha · 08/22 17:16
More
About PPBT
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Webull offers kinds of Purple Biotech Ltd - ADR stock information, including NASDAQ:PPBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PPBT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PPBT stock methods without spending real money on the virtual paper trading platform.